Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Form 8-K

sec.gov

8-K — LiveOne, Inc.

Accession: 0001213900-26-047074

Filed: 2026-04-23

Period: 2026-04-17

CIK: 0001491419

SIC: 5812 (RETAIL-EATING PLACES)

Item: Entry into a Material Definitive Agreement

Item: Financial Statements and Exhibits

Documents

8-K — ea0286923-8k_liveone.htm (Primary)

EX-5.1 — OPINION OF FOLEY SHECHTER ABLOVATSKIY LLP REGARDING THE SHARES (ea028692301_ex5-1.htm)

EX-10.1 — SHARES ISSUANCE AGREEMENT, DATED AS OF APRIL 17, 2026, BY AND BETWEEN THE COMPANY AND BROADCAST MUSIC, LLC (ea028692301_ex10-1.htm)

GRAPHIC (ea028692301_ex5-1img1.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0286923-8k_liveone.htm · Sequence: 1

false

0001491419

0001491419

2026-04-17

2026-04-17

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities

Exchange Act of 1934

Date of Report (Date of earliest event reported):

April 17, 2026

LIVEONE, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-38249

98-0657263

(State or other jurisdiction

of incorporation)

(Commission File Number)

(I.R.S. Employer

Identification No.)

269 South Beverly Drive, Suite 1450

Beverly Hills, CA 90212

(Address of principal executive offices) (Zip Code)

(310) 601-2505

(Registrant’s telephone number, including area

code)

n/a

(Former name or former address, if changed since last

report.)

Check the appropriate box below if the Form 8-K filing

is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction

A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b)

of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $0.001 par value per share

LVO

The NASDAQ Capital Market

Indicate by check mark whether the registrant is an

emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities

Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging

growth company ☐

If

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement.

On April 17, 2026, LiveOne,

Inc. (the “Company”), Slacker, Inc., the Company’s wholly owned subsidiary (“Slacker”), and Broadcast Music,

LLC (“BMI”) entered into a Shares Issuance Agreement (the “Shares Issuance Agreement”) pursuant to which the Company

agreed to issue to BMI or its designee 1,000,000 shares (the “Shares”) of its common stock, $0.001 par value per share (the

“common stock”), at a deemed issued price of $7.50 per share. The Shares will be issued as payment in full satisfaction of

any payment and music royalty payment obligations due through March 31, 2027 under the Slacker Music Service Music Performance License

Fee Agreement, dated as of November 20, 2024, and the Final License Fee Agreement and Release, dated as of November 20, 2024, each as

amended on April 17, 2026 (the “Amendment” and collectively, the “License Agreements”), between BMI and Slacker.

Pursuant to the Amendment, the parties also agreed to extend the term of the License Agreements through December 31, 2027 (the “Extended

Term”), and thereafter the License Agreements will automatically renew on a calendar year-to-year basis. To the extent any obligations

under the License Agreements remain payable to BMI for any period subsequent to April 1, 2027, Slacker will pay such remaining amounts

to BMI in immediately available funds.

Pursuant to the Shares Issuance

Agreement, BMI has agreed (for itself and on behalf of its designee) not to sell on any trading day an aggregate amount of Shares in excess

of 5% of the average daily trading volume for the Company’s common stock for the preceding 20 consecutive trading days (excluding

from such average any index rebalancing days) (“ADTV”). Notwithstanding the foregoing, regardless of the ADTV, BMI (and its

designee) is permitted to sell on any trading day at least 3,500 Shares.

The Shares will be issued to BMI or its designee pursuant to the Company’s

effective shelf Registration Statement on Form S-3 (File No. 333-284916), which was filed with the U.S. Securities and Exchange Commission

(the “SEC”) on February 13, 2025 (the “Registration Statement”), and a prospectus supplement relating to the offering

of the Shares filed with the SEC on April 23, 2026. The settlement of the issuance of the Shares is expected to take place on or about

April 24, 2026. The Company will not receive any cash proceeds from the offering of the Shares.

The

foregoing description of the Shares Issuance Agreement does not purport to be complete and is qualified in its entirety by reference to

the full text of the Shares Issuance Agreement which is filed as Exhibit 10.1 to this Current Report on Form 8-K (this “Current

Report”) and is incorporated herein by reference.

The legal opinion, including

the related consent, of Foley Shechter Ablovatskiy LLP, the Company’s outside corporate and securities counsel, are filed as Exhibits

5.1 and 23.1, respectively, to this Current Report.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit

Number

Description

5.1*

Opinion of Foley Shechter Ablovatskiy LLP regarding the Shares.

10.1*

Shares Issuance Agreement, dated as of April 17, 2026, by and between the Company and Broadcast Music, LLC.

23.1*

Consent of Foley Shechter Ablovatskiy LLP (included in Exhibit 5.1).

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

*

Filed herewith.

1

SIGNATURES

Pursuant to the requirements

of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

LIVEONE, INC.

Dated: April 23, 2026

By:

/s/ Ryan Carhart

Name:

Ryan Carhart

Title:

Chief Financial Officer

2

EX-5.1 — OPINION OF FOLEY SHECHTER ABLOVATSKIY LLP REGARDING THE SHARES

EX-5.1

Filename: ea028692301_ex5-1.htm · Sequence: 2

Exhibit 5.1

641 Lexington Ave. | 14th Floor

New York, NY 10022

Dial: 212.335.0466

Fax: 917.688.4092

info@foleyshechter.com

www.foleyshechter.com

April 23, 2026

LiveOne, Inc.

269 S. Beverly Drive, Suite 1450

Beverly Hills, CA 90212

Ladies and Gentlemen:

This opinion is furnished

to you in connection with a Prospectus Supplement, dated April 17, 2026, to a Prospectus dated February 26, 2025 (the “Prospectus

and Prospectus Supplement”), filed pursuant to a Registration Statement on Form S-3 (Registration No. 333-284916) (the “Registration

Statement”), filed by LiveOne, Inc., a Delaware corporation (the “Company”), with the U.S. Securities and Exchange Commission

(the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”), which became effective

on February 26, 2025, with respect to 1,000,000 shares (the “Shares”) of the Company’s common stock, $0.001 par value

per share (the “Common Stock”). The Shares are being offered and issued to Broadcast Music, LLC (“BMI”), pursuant

to that certain Shares Issuance Agreement, dated April 17, 2026 (the “Shares Issuance Agreement”), by and among the Company,

Slacker, Inc., the Company’s wholly owned subsidiary (“Slacker”), and BMI, as payment in full satisfaction of any payment

and music royalty payment obligations due through March 31, 2027 under the Slacker Music Service Music Performance License Fee Agreement,

dated as of November 20, 2024, and the Final License Fee Agreement and Release, dated as of November 20, 2024, each as amended on April

17, 2026 (the “Amendment” and collectively, the “License Agreements”), between BMI and Slacker. The Shares Issuance

Agreement is filed as an exhibit to a Current Report on Form 8-K, as filed with the Commission on April 23, 2026, and incorporated by

reference into the Registration Statement. All capitalized terms used herein and not otherwise

defined shall have the respective meanings given to them in the Registration Statement.

In connection with this

opinion, we have examined originals or copies, certified or otherwise identified to our satisfaction, of: (i) the Company’s

Certificate of Incorporation, as amended through the date hereof; (ii) the Company’s Bylaws, as amended through the date hereof;

(iii) certain resolutions of the Company’s Board of Directors (the “Board”) relating to the issuance, sale and

registration of the Shares; (iv) the Registration Statement, together with the exhibits thereto filed with the Commission; (v) the Prospectus

and Prospectus Supplement; (vi) such other records of the corporate proceedings of the Company and certificates of the Company’s

officers as we have deemed relevant; and (vii) the Shares Issuance Agreement, the License Agreements and the transactions contemplated

thereby. In addition, we have examined originals or copies, certified or otherwise identified to our satisfaction, of certain other corporate

records, documents, instruments and certificates of public officials and of the Company, and we have made such inquiries of officers of

the Company and public officials and considered such questions of law as we have deemed necessary for purposes of rendering the opinions

set forth herein. Our opinions are limited to the matters stated herein and no opinion is implied or may be inferred beyond the matters

expressly stated. As to certain factual matters, we have relied upon a certificate of an officer of the Company and have not sought to

independently verify such matters.

When relevant facts were

not independently established, we have relied without independent investigation as to matters of fact upon statements of governmental

officials and upon representations made in or pursuant to the Registration Statement and certificates or statements of appropriate representatives

of the Company.

In our examination of the

foregoing, we have assumed the genuineness of all signatures, the legal competence and capacity of natural persons, the authenticity of

documents submitted to us as originals and the conformity with authentic original documents of all documents submitted to us as copies

or by facsimile or other means of electronic transmission, or which we obtained from the Commission’s Electronic Data Gathering,

Analysis and Retrieval system (“Edgar”) or other sites maintained by a court or governmental authority or regulatory body

and the authenticity of the originals of such latter documents. If any documents we examined in printed, word processed or similar form

has been filed with the Commission on Edgar or such court or governmental authority or regulatory body, we have assumed that the document

so filed is identical to the document we examined except for formatting changes.

Based upon the foregoing

and subject to the assumptions, qualifications and limitations set forth herein, we are of the opinion that the Shares have been authorized

for issuance and, when the Shares are issued and paid for in accordance with the Shares Issuance Agreement and the Prospectus and Prospectus

Supplement, and assuming that the Shares have been and remain duly reserved for issuance within the limits of the Common Stock then remaining

authorized but unissued, the Shares will be validly issued, fully paid and non-assessable.

In addition to the assumptions,

comments, qualifications, limitations and exceptions set forth above, the opinion set forth herein is further limited by, subject to and

based upon the following assumptions, comments, qualifications, limitations and exceptions: our opinion herein reflects only the application

of the General Corporation Law of the State of Delaware (including the statutory provisions, the applicable provisions of the Delaware

Constitution and reported judicial decisions interpreting the foregoing). We express no opinion herein as to any other laws, statutes,

regulations or ordinances. Please note that we are opining only as to the matters expressly set forth herein, and no opinion should

be inferred as to any other matters. The opinion set forth herein is made as of the date hereof and is subject to, and may be limited

by, future changes in factual matters, and we undertake no duty to advise you of the same. The opinion expressed herein is based upon

the law in effect (and published or otherwise generally available) on the date hereof, and we assume no obligation to revise or supplement

this opinion should such law be changed by legislative action, judicial decision or otherwise. In rendering our opinion, we have not considered,

and hereby disclaim any opinion as to, the application or impact of any laws, cases, decisions, rules or regulations of any other jurisdiction,

court or administrative agency.

We understand that you wish

to file this opinion with the Commission as an exhibit to a Current Report on Form 8-K for incorporation by reference into the Registration

Statement in accordance with the requirements of Item 601(b)(5) of Regulation S-K promulgated under the Securities Act and to reference

the firm’s name under the caption “Legal Matters” in the Prospectus Supplement, and we hereby consent thereto. In giving

this consent, we do not admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act

or the rules and regulations of the Commission promulgated thereunder.

Sincerely yours,

/s/ Foley Shechter Ablovatskiy LLP

EX-10.1 — SHARES ISSUANCE AGREEMENT, DATED AS OF APRIL 17, 2026, BY AND BETWEEN THE COMPANY AND BROADCAST MUSIC, LLC

EX-10.1

Filename: ea028692301_ex10-1.htm · Sequence: 3

Exhibit 10.1

SHARES

ISSUANCE AGREEMENT

This  SHARES ISSUANCE

AGREEMENT (this “Agreement”), dated as of April 17, 2026 and effective as of March 31, 2026 (the “Effective

Date”), is by and among LiveOne, Inc., a Delaware corporation (the “Company”), and Slacker, Inc., a Delaware

corporation (“Slacker”), on the one hand, and Broadcast Music, LLC, a Delaware limited liability company (“BMI”),

on the other hand.

RECITALS

A. BMI

is entitled to certain payments (the “Fee”) from Slacker, Inc., the Company’s wholly owned subsidiary, due under

the Slacker Music Service Music Performance License Fee Agreement, dated as of November 20, 2024 (as amended, modified or restated from

time to time, the “License Fee Agreement”), and the Final License Fee Agreement and Release, dated as of November 20,

2024 (as amended, modified or restated from time to time, the “Final License Fee Agreement” and together with the License

Fee Agreement, the “Subject Agreement”), each entered into between BMI and Slacker.

B. BMI

and Slacker have also entered into an amendment to the Subject Agreement, dated as of the date hereof (the “Amendment”).

C. Pursuant

to the Amendment, BMI agrees to release Slacker from the Released Claims (as defined therein) in exchange for the issuance by Company

to BMI of 1,000,000 shares (the “Shares”) of the Company’s common stock, $0.001 par value per share (the “Common

Stock”), on the terms of this Agreement and the Amendment.

C. The

Share Issuance (as defined below) shall be made pursuant to the Company’s currently effective shelf Registration Statement on Form

S-3, which includes the Common Stock registered thereunder (Registration No. 333-284916) (the “Registration Statement”),

which Registration Statement has been declared effective in accordance with the Securities Act of 1933, as amended (the “1933

Act”), by the U.S. Securities and Exchange Commission (the “SEC”).

NOW, THEREFORE, in consideration

of the recitals above incorporated herein by this reference and the mutual covenants contained herein and for other good and valuable

consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and BMI hereby agree as follows:

1. In

Satisfaction of Released Claims. In satisfaction of the Released Claims, BMI agrees to accept the Share Issuance as provided in Section

2 below. The receipt by BMI of the Shares is a condition precedent to the effectiveness of the Amendment, and any failure by the Company

or Slacker to provide such compensation as provided herein, in whole or in part, shall render this Agreement and the Amendment null and

void.

2. Issuance

of Shares.

(a)  Subject

to the terms of Section 2(b) below, the Company shall effectuate the issuance of the Shares by providing the TA Instructions as set forth

in Section 4 below (the “Share Issuance”). The closing (the “Closing”) of the offer and purchase

of the Shares by BMI shall occur virtually at the offices of Foley Shechter Ablovatskiy LLP, the Company’s outside corporate and

securities counsel by no later than five (5) business days after the date of this Agreement. As used herein “Business Day”

means any day other than a Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or required by

law to remain closed. The parties agree that the conditions to closing (the “Closing”) are (i) delivery by each party

to the other party of this Agreement and the Amendment, duly executed by such first party (and Slacker, with respect to the Company),

and (ii) confirmation by the Transfer Agent (as defined below) that the Shares have been issued to BMI as provided in Section 4 of this

Agreement (collectively, the “Closing Conditions”). The date on which the Closing occurs shall be referred to herein

as the “Closing Date”. Without prejudice to any other Section of this Agreement regarding how the Shares shall be valued

towards the Released Claims, the parties hereto agree and acknowledge that the shares shall be deemed issued at a price of $7.50 per share.

1

(b) The

parties hereto agree and acknowledge that notwithstanding the parties hereto entering into this Agreement, the Company shall not be under

any obligation and shall not have any liability whatsoever to BMI under the Subject Agreement, the Amendment or otherwise except for the

Company’s obligation to issue the Shares on the terms of this Agreement.

(c) BMI

agrees not to sell on any trading day an aggregate amount of the Shares that is more than five percent (5%) of the average daily trading

volume for the Common Stock for the preceding twenty (20) consecutive trading days (excluding from such average any index rebalancing

days) (such average daily trading volume, “ADTV”, and such five percent (5%) cap, the “Daily Trading Cap”); provided,

however, that in the event the Common Stock is not traded on a securities exchange or automated quotation system, “Daily Trading

Cap” shall mean five percent (5%) of the shares of Common Stock issued to BMI pursuant to this Amendment. Notwithstanding the foregoing,

regardless of the ADTV, BMI shall be permitted to sell on any trading day at least 3,500 shares of the Shares.

2. BMI’s

Representations and Warranties. BMI represents and warrants to the Company that, as of the date hereof and as of the date of the Closing:

(a) (i) the execution

and delivery of this Agreement and Amendment by BMI, and the consummation by BMI of the transactions contemplated hereby and thereby,

have been duly and validly authorized, executed and delivered on behalf of BMI and shall constitute the legal, valid and binding obligations

of BMI enforceable against BMI in accordance with its respective terms, except as such enforceability may be limited by general principles

of equity or to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting

generally, the enforcement of applicable creditors’ rights and remedies, and (ii) the person executing this Agreement and the Amendment

on its behalf has the authority to do so.

(b) BMI acknowledges

and represents that: (a) it has read the Agreement; (b) it clearly understands the Agreement and each of its terms; (c) it fully and unconditionally

consent to the terms of this Agreement; (d) it had the benefit and advice of counsel of its own selection; (e) it has executed this Agreement,

freely, with knowledge, and without influence or duress; (f) it has not relied upon any other representations, either written or oral,

express or implied, made to them by any person; and (g) the consideration received by it has been actual and adequate.

3. Representations

and Warranties of the Company. The Company represents and warrants to BMI that, as of the date hereof and as of the date of the Closing:

(a) The

Company is duly incorporated, validly existing and in good standing under the laws of the jurisdiction of its incorporation, with the

requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. The Company

is not in violation or default of any of the provisions of its articles of incorporation, bylaws or other organizational or charter documents.

The Company is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction

in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to

be so qualified or in good standing, as the case may be, could not reasonably be expected to result in (i) a material adverse effect on

the legality, validity or enforceability of this Agreement, (ii) a material adverse effect on the results of operations, assets, business

or financial condition of the Company, or (iii) a material adverse effect on the Company’s ability to enter into or perform in any

material respect its obligations under this Agreement, including, without limitation, the ability of the Company to issue the Shares as

provided herein. The Company is not a party to any legal or regulatory proceeding and no such proceeding has been instituted in any such

jurisdiction which, in either case, revokes, limits or curtails or seeks to revoke, limit or curtail, such power and authority or qualification.

2

(b) The

Company has the requisite power and authority to enter into and perform its obligations under this Agreement and make the Share Issuance

in accordance with the terms hereof and thereof. The execution and delivery of this Agreement by the Company, and the consummation by

the Company of the transactions contemplated hereby have been duly authorized by the Company’s board of directors and (other than

(x) the filing with the SEC of the prospectus supplement related to the Shares required by Rule 424(b) under the 1933 Act (the “Prospectus

Supplement”) supplementing the base prospectus forming part of the Registration Statement (such base prospectus as so supplemented,

the “Prospectus”) and (y) any other filings as may be required by any state or federal securities agencies (collectively,

the “Required Filings”)) no further filing, consent or authorization is required by the Company, its subsidiaries,

their respective boards of directors or their stockholders or other governing body. This Agreement has been duly executed and delivered

by the Company, and when duly executed by BMI, shall constitute the legal, valid and binding obligations of the Company, enforceable against

the Company in accordance with its respective terms, except as such enforceability may be limited by general principles of equity or applicable

bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of

applicable creditors’ rights and remedies and except as rights to indemnification and to contribution may be limited by federal

or state securities law.

(c) The Shares are

duly authorized and shall be validly issued, fully paid and non-assessable and free from all preemptive or similar rights, mortgages,

defects, claims, liens, pledges, charges, taxes, rights of first refusal, encumbrances, security interests and other encumbrances (collectively

“Liens”) with respect to the issuance thereof. The Shares shall be registered under the 1933 Act, and the Shares shall

be issued pursuant to the Registration Statement, Prospectus Supplement and Prospectus and as such shall be freely transferable and freely

tradable by BMI without restriction, whether by way of registration or some exemption therefrom. The Registration Statement is effective

and available for the issuance of the Common Stock thereunder and the Company has not received any notice that the SEC, or any trading

market on which the Common Stock is or has been listed, has issued or intends to issue a stop-order with respect to the Registration Statement

or that the SEC, or any trading market on which the Common Stock is or has been listed, otherwise has suspended or withdrawn the effectiveness

of the Registration Statement, either temporarily or permanently, or intends or has threatened in writing to do so. The Company has not

taken any action which is designed to or likely to have the effect to terminate the Registration Statement under the 1933 Act. There has

not been, and, to the knowledge of the Company, there is not pending or contemplated, any investigation by the SEC involving the Company

or any current or former director or officer of the Company. The Registration Statement and any prospectus included therein, including

the Prospectus, and all other reports, schedules, forms, statements and other documents required to be filed by the Company since April

1, 2024 pursuant to the Securities Exchange Act of 1934, as amended (the “1934 Act”), and the Registration Statement

and the Prospectus, collectively the “SEC Reports”), complied in all material respects with the requirements of the

1933 Act, and the documents incorporated by reference into the Registration Statement when filed, complied in all material respects with

the requirements of the 1934 Act and, in each case, with the rules and regulations of the SEC promulgated under the 1933 Act or the 1934

Act, as the case may be. At the time the Registration Statement and any amendments thereto became effective the Registration Statement

and any amendments thereto complied with and, upon the filing of the Prospectus Supplement after the date of this Agreement the Registration

Statement, will comply in all material respects with the requirements of the 1933 Act and will not contain any untrue statement of a material

fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading. The

Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued and

the Prospectus Supplement at the Closing Date, complied and will comply, as the case may be, in all material respects with the requirements

of the 1933 Act. Since April 1, 2024, the Company has filed the SEC Reports on a timely basis or filed an appropriate extension of such

time of filing and filed any such SEC Reports prior to the expiration of any such extension. The SEC Reports did not, and will not, contain

any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in light of

the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply

in all material respects with applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in effect

at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles

applied on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial

statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly

present in all material respects the financial position of the Company and its consolidated subsidiaries as of and for the dates thereof

and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial,

year-end audit adjustments. The SEC has not notified the Company of any objection to the use of the form of the Registration Statement

pursuant to Rule 401(g)(1) under the 1933 Act. The Registration Statement meets the requirements set forth in Rule 415(a)(1)(x) under

the 1933 Act.

3

(c) The Company

acknowledges and represents that: (a) it has read the Agreement; (b) it clearly understands the Agreement and each of its terms; (c)

it fully and unconditionally consent to the terms of this Agreement; (d) it had the benefit and advice of counsel of its own

selection; (e) it has executed this Agreement, freely, with knowledge, and without influence or duress; (f) it has not relied upon

any other representations, either written or oral, express or implied, made to them by any person; and (g) the consideration

received by it has been actual and adequate.

4. Transfer

Agent Instructions; No Legend. Upon the full execution of this Agreement and the Amendment by the Company, Slacker and BMI, as applicable,

the Company shall promptly, but in any event, within two (2) business days, provide its irrevocable instructions (the “TA Instructions”)

to VStock Transfer, LLC, its transfer agent (the “Transfer Agent”), to issue the Shares in book-entry form or credit

the Shares to the applicable balance accounts at DTC, registered in the name of BMI or its respective nominee(s), as requested by BMI,

in such amounts as specified by BMI to the Company. The Company represents and warrants that no instruction other than the TA Instructions

referred to in this Section will be given by the Company to its transfer agent with respect to the Shares, and that the Shares shall otherwise

be freely transferable on the books and records of the Company, as applicable, to the extent provided in this Agreement. The Company shall

cause its counsel to issue the legal opinion required by the Transfer Agent in connection with the issuance of the Shares to BMI as provided

herein. Any fees with respect to the transfer agent or counsel to the Company associated with such issuance shall be borne by the Company. Certificates

and any other instruments evidencing the Shares shall not bear any restrictive or other legend.

5.

Termination. BMI shall be entitled to terminate this Agreement and the Subject Agreement and the Amendment on the terms

hereof and thereof in the event that Company fails to make the Share Issuance in accordance with the terms hereof.

6. Registration and

Public Disclosure.

(a)  Until

such time that BMI no longer owns any of the Shares, the Company covenants to maintain the registration of the Common Stock under Section

12(b) or 12(g) of the 1934 Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace period)

all reports required to be filed by the Company after the date hereof pursuant to the 1934 Act even if the Company is not then subject

to the reporting requirements of the 1934 Act.

4

(b) The

Company shall within the time required by the 1934 Act issue a Current Report on Form 8-K disclosing the material terms of the transactions

contemplated hereby (the “Form 8-K”). From and after the issuance of the Form 8-K, the Company represents to BMI that

the Company shall have publicly disclosed all material, non-public information delivered to BMI as of such time by the Company, or any

of its respective officers, directors, employees or agents in connection with the Share Issuance. The Company shall afford BMI and its

counsel with a reasonable opportunity (email shall suffice) to timely review and comment upon, shall consult with BMI and its counsel

on the form and substance of, and shall give due consideration to all such timely comments from BMI counsel on, any press release, filing

with the SEC or any other public disclosure made by or on behalf of the Company relating to BMI, the Share Issuance and/or the Released

Claims, prior to the issuance, filing or public disclosure thereof, and the Company shall not issue any press release or publicity or

promotional materials without the prior consent of BMI, or otherwise issue, file or publicly disclose any such information to which BMI

shall reasonably object, except if and only to the extent required by applicable law, rule or regulation; provided that if BMI shall not

respond to the Company at least one business day prior to the due date of the Form 8-K, BMI shall be deemed to have agreed to the form

and substance of the Form 8-K.

(c)  Except

as for the transactions contemplated by this Agreement, the Company confirms that neither it nor any other person acting on its behalf

shall provide BMI or its agents or counsel with any information that constitutes or might constitute material, non-public information,

unless a simultaneous public announcement thereof is made by the Company in the manner contemplated by Regulation FD. In the event of

a breach of the foregoing covenant by the Company or any person acting on its behalf (as determined in the reasonable good faith judgment

of BMI), in addition to any other remedy provided herein, in the Subject Agreement or in the Amendment, if BMI is holding any securities

of the Company at the time of the disclosure of material, non-public information, BMI shall have the right to make a public disclosure,

in the form of a press release, public advertisement or otherwise, of such material, non-public information without the prior approval

by the Company; provided BMI shall have first provided a prior written notice (email shall suffice) to the Company that it believes it

has received information that constitutes material, non-public information, the Company shall have four (4) business days publicly to

disclose such material, non-public information prior to any such disclosure by BMI or demonstrate to BMI in writing why such information

does not constitute material, non-public information, and (assuming BMI and BMI’s counsel reasonably disagree with the Company’s

determination) the Company shall have failed to publicly disclose such material, non-public information within such time period. BMI shall

not have any liability to the Company or any of its subsidiaries, or any of their respective directors, officers, employees, stockholders

or agents, for any such disclosure. The Company understands and confirms that BMI shall be relying on the foregoing covenants and obligations

in agreeing to the Amendment, including the release of the Released Claims, and this Agreement.

7.

Miscellaneous.

(a)  Choice of

Law; Venue. This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by and

construed in accordance with the laws of the State of New York, without regard to the conflict of laws principles thereof. Any action

or proceeding seeking to enforce any provision of, or based on any right arising out of, this Agreement may be brought against a party

hereto in any state or federal court located in the City of New York, State of New York, and each party hereto consents to the jurisdiction

of such courts (and of the appropriate appellate courts) in any such action or proceeding and waives any objection to venue laid therein.

Process in any action or proceeding referred to in the preceding sentence may be served on any party hereto anywhere in the world.

(b) Attorneys’

Fees and Costs. Each of the parties will bear their own costs and expenses, including but not limited to any costs, forum

fees or attorneys’ fees incurred in connection with the negotiation and execution of this Agreement, the Amendment and any

other ancillary agreements and documents.

5

(c) Headings;

Gender. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation

of, this Agreement. Unless the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine,

neuter, singular and plural forms thereof. The terms “including,” “includes,” “include” and words

of like import shall be construed broadly as if followed by the words “without limitation.” The terms “herein,”

“hereunder,” “hereof” and words of like import refer to this entire Agreement instead of just the provision in

which they are found.

(d) Severability. If

any term, provision, agreement, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be

invalid, void or unenforceable, the remainder of the terms, provisions, agreements, covenants and restrictions of this Agreement

shall remain in full force and effect and shall in no way be affected, impaired or invalidated so long as the economic or legal

substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party hereto. Upon such a

determination, the parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties

hereto as closely as possible in a reasonably acceptable manner so that the transactions contemplated hereby may be consummated as

originally contemplated to the fullest extent possible.

(e) Entire Agreement;

Amendments; Effectiveness. This Agreement supersedes all other prior oral or written agreements between the parties and contains

the entire understanding of the parties solely with respect to the matters covered herein, other than the Subject Agreement. For clarification

purposes, the Recitals are part of this Agreement, and the Subject Agreement and the Amendment remain in full force and effect after the

Closing Date. No provision of this Agreement may be amended or waived other than by an instrument in writing signed by the Company and

BMI. This Agreement shall become effective and binding upon the parties hereto as of the Effective Date upon the satisfaction of

all of the Closing Conditions.

(f) Notices. Any

notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in writing

and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by electronic mail;

or (iii) one (1) Business Day after deposit with an overnight courier service with next day delivery specified, in each case, properly

addressed to the party to receive the same. The addresses and e-mail addresses for such communications shall be:

If to the Company or Slacker (as applicable):

If to BMI:

LiveOne, Inc./Slacker, Inc.

Broadcast Music, LLC

269 South Beverly Drive, Suite 1450

7 World Trade Center

Beverly Hills, CA 90212

250 Greenwich Street

Attention: CEO

New York, NY 10007

Email: rob@liveone.com and tenia@liveone.com

Attention: SVP, Licensing

And a separate copy tto:

with a copy (which shall not constitute notice) to:

Attention: SVP, Chief Legal Officer

Foley Shechter Ablovatskiy LLP

Email: digitalaccount@bmi.com

641 Lexington Avenue, 14th Floor

New York, NY 10022

with a copy (which shall not constitute notice) to:

Attention: Sasha Ablovatskiy, Esq.

__________________

Email: sablovatskiy@foleyshechter.com

__________________

__________________

Attention: __________________

Email: __________________

or to such other address,

e-mail address and/or facsimile number and/or to the attention of such other person as the party hereto has specified by written notice

given to each other party five (5) days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the party

hereto of such notice, consent, waiver or other communication or (B) provided by an overnight courier service shall be rebuttable evidence

of personal service or receipt from an overnight courier service in accordance with clause (i), (ii) or (iii) above, respectively.

6

(g) Successors and Assigns. This

Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns, including any purchasers

of any of the Shares. Neither party shall assign this Agreement or any rights or obligations hereunder without the prior written consent

of the other party.

(h) No Third Party

Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns,

and is not for the benefit of, nor may any provision hereof be enforced by, any other person, other than the indemnitees referred to above.

(i) Survival.

The representations, warranties, agreements and covenants shall survive the Closing.

(j) Further Assurances.

Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all

such other agreements, certificates, instruments and documents, as any other party may reasonably request in order to carry out the intent

and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

(k) Construction.

The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules

of strict construction will be applied against any party. No specific representation or warranty shall limit the generality or applicability

of a more general representation or warranty. Each and every reference to share prices, shares of Common Stock and any other numbers in

this Agreement that relate to the Common Stock shall be automatically adjusted for any stock splits, stock dividends, stock combinations,

recapitalizations or other similar transactions that occur with respect to the Common Stock after the date of this Agreement. This

Agreement shall be construed without regard to any presumptions against the Party causing the same to be prepared.

(l) Remedies.

Any person having any rights under any provision of this Agreement shall be entitled to enforce such rights specifically (without posting

a bond or other security), to recover damages by reason of any breach of any provision of this Agreement and to exercise all other rights

granted by law. The parties each agree that money damages may not be a sufficient remedy for any breach of this Agreement by the other

and that in addition to all other remedies, each party shall be entitled to seek specific performance and injunctive or other equitable

relief as a remedy for any such breach.

7

(m) Liability.

Notwithstanding any provision of this Agreement and/or the Subject Agreement to the contrary, BMI agrees that none of the officers, directors,

employees, advisors, consultants, agents, representatives, shareholders, members or affiliates of the Company and/or Slacker nor their

respective affiliates, if any, controlling such persons, will have any liability or any other obligation (whether direct or indirect,

in contract or tort or otherwise) to BMI and/or any of its affiliates for or in connection with issuance of shares as described herein

except for any such liability for losses, claims, damages or liabilities incurred by Slacker that are finally judicially determined to

have resulted from the gross negligence or willful misconduct of such individuals or entities.

(n) Confidentiality.

Except as may be required by applicable law, neither of the parties hereto shall make any disclosure concerning this Agreement or the

terms hereof except to its employees and representatives as may be necessary or advisable, including but not limited to legal counsel,

accountants or other advisors without prior approval by the other party; provided, however, that nothing in this Agreement shall restrict

the Company from making any disclosures that may be required by the federal securities laws including (without limitation) appropriate

disclosures if so required by applicable items of the Form 8-K, the 1933 Act or Regulation FD, as such disclosure may be incorporated

into the Company’s Forms 8-K, 10-Q and 10-K. Notwithstanding the foregoing, upon any disclosure concerning this Agreement made in

accordance with the federal securities laws, the restrictions contained in this paragraph shall terminate as of the date of such disclosure

and be of no further force and effect.

(o) Counterparts. This

Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and shall

become effective when counterparts have been signed by each party and delivered to the other party. In the event that any signature is

delivered by an e-mail which contains a portable document format (.pdf) file of an executed signature page, such signature page shall

create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect

as if such signature page were an original thereof.

[Signature page follows]

8

IN WITNESS WHEREOF, BMI

and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written above.

COMPANY:

LIVEONE, INC.

By:

/s/ Robert Ellin

Name:

Robert Ellin

Title:

CEO and Chairman

BROADCAST MUSIC, LLC

By:

/s/ David Levin

Name:

David Levin

Title:

Sr. VP of Licensing

Agreed to and acknowledged this

17th day of April 2026:

SLACKER, INC.

By:

/s/ Robert Ellin

Name:

Robert Ellin

Title:

CEO

9

GRAPHIC

GRAPHIC

Filename: ea028692301_ex5-1img1.jpg · Sequence: 4

Binary file (9395 bytes)

Download ea028692301_ex5-1img1.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 9

v3.26.1

Cover

Apr. 17, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Apr. 17, 2026

Entity File Number

001-38249

Entity Registrant Name

LIVEONE, INC.

Entity Central Index Key

0001491419

Entity Tax Identification Number

98-0657263

Entity Incorporation, State or Country Code

DE

Entity Address, Address Line One

269 South Beverly Drive

Entity Address, Address Line Two

Suite 1450

Entity Address, City or Town

Beverly Hills

Entity Address, State or Province

CA

Entity Address, Postal Zip Code

90212

City Area Code

310

Local Phone Number

601-2505

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common stock, $0.001 par value per share

Trading Symbol

LVO

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

X

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

na

Period Type:

duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration